Search

Your search keyword '"Winkler, Martin S."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Winkler, Martin S." Remove constraint Author: "Winkler, Martin S."
36 results on '"Winkler, Martin S."'

Search Results

4. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

7. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge

8. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

11. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant

12. Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75

13. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy

14. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3

15. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination

16. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

17. Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies

18. Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19

19. The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic

20. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination

21. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

22. Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination

23. Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination

24. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

25. Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination

26. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

28. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

29. S1P lyase inhibition protects against sepsis by promoting disease tolerance via the S1P/S1PR3 axis

30. Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients

31. Syndecan-1 as a biomarker for sepsis survival after major abdominal surgery

33. Sphingosine-1-Phosphate

36. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Catalog

Books, media, physical & digital resources